Cheng Xie

Synthesis, cytotoxicity, metabolic stability and pharmacokinetic evaluation of fluorinated docetaxel analogs.

G. Lin, Hong-Fu Lu, Cheng Xie, 2011, European journal of medicinal chemistry.

(1S,2S,3R,4S,5R,7S,8S,10R,13S)-2-Debenzoyl-10-deacetyl-2-(3-fluorobenzoyl)-7,10-bis(2,2,2-trichloroethoxycarbonyl)baccatin III ethyl acetate monosolvate monohydrate

Hong-Fu Lu, Cheng Xie, Jun Chang, 2011, Acta crystallographica. Section E, Structure reports online.

Mitochondrial-targeted prodrug cancer therapy using a rhodamine B labeled fluorinated docetaxel.

Hong-Rui Liu, Cheng Xie, Jun Chang, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Synthesis and Crystal Studies of Novel C(10) Modified Taxanes from 1-Deoxybaccatin VI

Cheng Xie, Haixia Lin, Yongmei Cui, 2019, Journal of Chemical Crystallography.

Design, synthesis of novel C-3′-N-sulfonyl modified taxane analogues from 1-deoxybaccatin VI and their impact on anti-HCC activity

Cheng Xie, W. Qiu, Haixia Lin, 2019, Journal of Asian natural products research.

Synthesis and biological activity of C-7, C-9 and C-10 modified taxane analogues from 1-deoxybaccatin VI.

Hongchun Liu, Min-min Zhang, Yongmei Cui, 2020, Bioorganic & medicinal chemistry.

Novel fluorinated docetaxel analog for anti-hepatoma: Molecular docking and biological evaluation.

Cheng Xie, Xun Sun, Lu Zhou, 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.